Mototsugu Oya

Intrarenal satellites of renal cell carcinoma: Histopathologic manifestation and clinical implication

Mototsugu Oya, Kaoru Nakamura, Shiro Baba et al. · Urology · 1995 · 51 citations

Urology, Tumoral Pathology, Genitourinary Cancer +9

Final overall survival (OS) in PROpel: Abiraterone (abi) and olaparib (ola) versus abiraterone and placebo (pbo) as first-line (1L) therapy for metastatic castration-resistant prostate cancer (mCRPC).

Noel W. Clarke, Andrew J. Armstrong, Antoine Thiery-Vuillemin et al. · Journal of Clinical Oncology · 2023 · 51 citations

Surgical Oncology, Clinical Endpoint, Prognosis +25

Visceral obesity is associated with better recurrence-free survival after curative surgery for Japanese patients with localized clear cell renal cell carcinoma

G. Kaneko, Akira Miyajima, Kazuyuki Yuge et al. · Japanese Journal of Clinical Oncology · 2014 · 43 citations · Full text

Prioritising Urological Surgery in the COVID-19 Era: A Global Reflection on Guidelines

Stavros Gravas, Georges Fournier, Mototsugu Oya et al. · European Urology Focus · 2020 · 27 citations · Full text

Preoperative Hydronephrosis: Independent Predictor for Changes in Renal Function Following Nephroureterectomy

Ken Hoshino, Eiji Kikuchi, Nobuyuki Tanaka et al. · Japanese Journal of Clinical Oncology · 2012 · 24 citations